Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for glecaprevir-pibrentasvir (Maviret) for chronic hepatitis C virus (HCV) infection in pediatric patients 3 years of age and older and weighing at least 12 kg.